학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 252건 | 목록 1~20
Academic Journal
Crown J; St. Vincent's University Hospital, Dublin, Ireland. Electronic address: john.crown@ccrt.ie.; Stroyakovskii D; Moscow City Oncology Hospital #62 of Moscow Healthcare Department, Moscow, Russia.; Yardley DA; Sarah Cannon Research Institute, Nashville, USA.; Huang CS; National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Fasching PA; University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.; Bardia A; David Geffen School of Medicine at UCLA, Los Angeles, USA; The UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, USA.; Chia S; BC Cancer, Vancouver, Canada.; Im SA; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.; Martin M; Instituto de Investigación Sanitaria Gregorio Marañon, Centro de Investigación Biomédica en Red de Cáncer, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid, Spain.; Xu B; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Barrios CH; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.; Untch M; Interdisciplinary Breast Cancer Center, Helios Klinikum Berlin-Buch, Berlin, Germany.; Moroose R; Orlando Health Cancer Institute, Orlando, USA.; Hurvitz SA; University of Washington, Fred Hutchinson Cancer Center, Seattle, USA.; Hortobagyi GN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Slamon DJ; David Geffen School of Medicine at UCLA, Los Angeles, USA.; Visco F; National Breast Cancer Coalition (NBCC), Washington, USA.; Spera G; Translational Research in Oncology (TRIO), Montevideo, Uruguay.; Zarate JP; Novartis Pharmaceuticals Corporation, East Hanover, USA.; Halligan D; Novartis Ireland Ltd, Dublin, Ireland.; Li Z; Novartis Pharmaceuticals Corporation, East Hanover, USA.; Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Caiazza F; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. francesco.caiazza@gmail.com.; McGowan PM; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.; Mullooly M; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.; Murray A; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.; Synnott N; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.; O'Donovan N; National Institute for Cellular Biotechnology (NICB), Dublin City University, Dublin, Ireland.; Flanagan L; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.; Tape CJ; Department of Oncology, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.; Cell Communication Team, Division of Cancer Biology, The Institute of Cancer Research, London, UK.; Murphy G; Department of Oncology, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.; Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Duffy MJ; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.; UCD Clinical Research Centre, St Vincent's University Hospital, Dublin, Ireland.
Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Hortobagyi GN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: ghortoba@mdanderson.org.; Lacko A; Dolnoslaskie Centrum Onkologii, Wroclaw, Poland.; Sohn J; Severance Hospital, Seoul, Korea.; Cruz F; Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil.; Ruiz Borrego M; Hospital Virgen del Rocio de Sevilla, Seville, Spain.; Manikhas A; Saint Petersburg City Clinical Oncology Dispensary, Saint Petersburg, Russia.; Hee Park Y; Samsung Medical Center, Seoul, Korea.; Stroyakovskiy D; Moscow City Oncology Hospital No. 62 of Moscow Healthcare Department, Moscow, Russia.; Yardley DA; Sarah Cannon Research Institute, Nashville, USA.; Huang CS; National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei City, Taiwan.; Fasching PA; University Hospital Erlangen Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.; Crown J; St Vincent's Private Hospital, Dublin, Ireland.; Bardia A; David Geffen School of Medicine at UCLA, Los Angeles, USA.; Chia S; BC Cancer - Vancouver, Vancouver, Canada.; Im SA; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red de Cáncer, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid, Spain.; Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia.; Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China.; Hurvitz S; University of Washington, Fred Hutchinson Cancer Center, Seattle, USA.; Barrios C; Latin American Cooperative Oncology Group, Porto Alegre, Brazil.; Untch M; Interdisciplinary Breast Cancer Center, Helios Klinikum Berlin-Buch, Berlin, Germany.; Moroose R; Orlando Health Cancer Institute, Orlando.; Visco F; National Breast Cancer Coalition, Washington, USA.; Parnizari F; TRIO - Translational Research in Oncology, Montevideo, Uruguay.; Zarate JP; Novartis Pharmaceuticals Corporation, East Hanover, USA.; Li Z; Novartis Pharmaceuticals Corporation, East Hanover, USA.; Waters S; Novartis Ireland, Dublin, Ireland.; Chakravartty A; Novartis Pharmaceuticals Corporation, East Hanover, USA.; Slamon D; David Geffen School of Medicine at UCLA, Los Angeles, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Eustace AJ; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland. alex.eustace@dcu.ie.; Madden SF; Data Science Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.; Fay J; Department of Histopathology, Royal College of Surgeons in Ireland, Dublin, Ireland.; Collins DM; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Kay EW; Department of Histopathology, Royal College of Surgeons in Ireland, Dublin, Ireland.; Sheehan KM; Department of Histopathology, Royal College of Surgeons in Ireland, Dublin, Ireland.; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.; Furney S; Department of Physiology, Royal College of Surgeons in Ireland, Dublin, Ireland.; Moran B; Conway Institute, University College Dublin, Dublin, Ireland.; Fagan A; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.; Morris PG; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.; Teiserskiene A; Cancer Trials Ireland, Dublin, Ireland.; Hill AD; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.; Grogan L; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.; Walshe JM; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Breathnach O; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.; Power C; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.; Duke D; Department of Radiology, Beaumont Hospital, Dublin, Ireland.; Egan K; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland.; Gallagher WM; Conway Institute, University College Dublin, Dublin, Ireland.; O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Crown J; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Cancer Trials Ireland, Dublin, Ireland.; Toomey S; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.; Hennessy BT; Cancer Trials Ireland, Dublin, Ireland.; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Jhaveri K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York. Electronic address: jhaverik@mskcc.org.; Eli LD; Clinical Development, Puma Biotechnology, Los Angeles, USA.; Wildiers H; University Hospitals Leuven, Leuven, Belgium.; Hurvitz SA; David Geffen School of Medicine, UCLA, Los Angeles, Santa Monica, USA.; Guerrero-Zotano A; Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Unni N; UT Southwestern Medical Center, Dallas.; Brufsky A; Magee-Womens Hospital of UPMC, Pittsburgh.; Park H; Washington University School of Medicine, St. Louis.; Waisman J; City of Hope Comprehensive Cancer Center, Duarte.; Yang ES; University of Alabama at Birmingham, Birmingham, USA.; Spanggaard I; Department of Oncology, Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark.; Reid S; Division of Hematology/Oncology (Breast Oncology), The Vanderbilt-Ingram Cancer Center, Nashville.; Burkard ME; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison.; Vinayak S; Seattle Cancer Care Alliance, Seattle, USA.; Prat A; Hospital Clínic de Barcelona, Barcelona, Spain.; Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif.; Bidard FC; Department of Medical Oncology, UVSQ/Paris-Saclay University, Institut Curie, Saint Cloud, France.; Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Crown J; St. Vincent's University Hospital, Dublin, Ireland.; Bhave M; Department of Hematology/Oncology, Emory University, Winship Cancer Institute, Atlanta.; Piha-Paul SA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston.; Suga JM; Kaiser Permanente, Department of Medical Oncology, Vallejo, USA.; Chia S; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada.; Saura C; Medical Oncology Service, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.; Garcia-Saenz JÁ; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid.; Gambardella V; Hospital Clínico de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia.; de Miguel MJ; START Madrid - Hospital Universitario Madrid Sanchinarro, Madrid, Spain.; Gal-Yam EN; Institute of Breast Oncology, Sheba Medical Center, Ramat Gan.; Rapael A; Sourasky Medical Center, Tel Aviv.; Stemmer SM; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva; Tel Aviv University, Tel Aviv, Israel.; Ma C; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis.; Hanker AB; UT Southwestern Simmons Comprehensive Cancer Center, Dallas.; Ye D; UT Southwestern Simmons Comprehensive Cancer Center, Dallas.; Goldman JW; UCLA Hematology & Oncology, Santa Monica.; Bose R; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis.; Peterson L; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis.; Bell JSK; Tempus Labs, Chicago, USA.; Frazier A; Clinical Development, Puma Biotechnology, Los Angeles, USA.; DiPrimeo D; Clinical Development, Puma Biotechnology, Los Angeles, USA.; Wong A; Clinical Development, Puma Biotechnology, Los Angeles, USA.; Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas.; Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Liddy S; Department of Radiology, St Vincent's University Hospital, Elm Park, Dublin 4, D04 T6F4 Ireland.; Duignan J; Department of Radiology, St Vincent's University Hospital, Elm Park, Dublin 4, D04 T6F4 Ireland.; Haughey A; Department of Radiology, St Vincent's University Hospital, Elm Park, Dublin 4, D04 T6F4 Ireland.; Crown J; Department of Oncology, St Vincent's University Hospital, Elm Park, Dublin 4, D04 T6F4 Ireland.; McNeill G; Department of Radiology, St Vincent's University Hospital, Elm Park, Dublin 4, D04 T6F4 Ireland.; Killeen RP; Department of Radiology, St Vincent's University Hospital, Elm Park, Dublin 4, D04 T6F4 Ireland.
Publisher: Published for the Association of Physicians of Great Britain and Ireland by the Oxford University Press Country of Publication: England NLM ID: 9438285 Publication Model: Print Cited Medium: Internet ISSN: 1460-2393 (Electronic) Linking ISSN: 14602393 NLM ISO Abbreviation: QJM Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Crown, J
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어